Quest Diagnostics Incorporated

NYSE:DGX Voorraadrapport

Marktkapitalisatie: US$18.3b

Quest Diagnostics Inkomsten in het verleden

Verleden criteriumcontroles 4/6

De winst van Quest Diagnostics is gedaald met een gemiddeld jaarlijks percentage van -5.7%, terwijl de winst van de Healthcare -industrie jaarlijks groeide met 5.4%. De inkomsten zijn groeide met een gemiddeld percentage van 3.1% per jaar. Het rendement op het eigen vermogen Quest Diagnostics bedraagt 12.9% en de nettomarge bedraagt 8.8%.

Belangrijke informatie

-5.7%

Groei van de winst

-1.8%

Groei van de winst per aandeel

Healthcare Groei van de industrie8.5%
Inkomstengroei3.1%
Rendement op eigen vermogen12.9%
Nettomarge8.8%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Nov 12
Investors Met With Slowing Returns on Capital At Quest Diagnostics (NYSE:DGX)

Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Oct 25
Earnings Update: Quest Diagnostics Incorporated (NYSE:DGX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat

Oct 24

Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Oct 23
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E

Quest Diagnostics: The Better Half Of An Emerging Healthcare Duopoly

Oct 15

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Feb 06
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 11
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Dec 24
Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Dec 06
Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Nov 18
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Quest Diagnostics: Moving Past Covid

Oct 25

Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

Sep 25
Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Sep 04
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Aug 13
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jul 11
Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Jun 09
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Quest Diagnostics: Healthier Diagnosis

May 30

Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

May 24
Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

May 09
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

Mar 22
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Feb 19
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Opbrengsten en kosten

Hoe Quest Diagnostics geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NYSE:DGX Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 249,5398381,6810
30 Jun 249,3468361,6240
31 Mar 249,2878421,6210
31 Dec 239,2528501,6150
30 Sep 239,2977591,7480
30 Jun 239,4887901,8250
31 Mar 239,6037891,8320
31 Dec 229,8839421,8180
30 Sep 2210,2941,2301,7360
30 Jun 2210,5821,4791,7050
31 Mar 2210,6791,8741,7150
31 Dec 2110,7881,9881,7230
30 Sep 2111,0462,1751,6740
30 Jun 2111,0582,2381,6420
31 Mar 2110,3351,7941,5710
31 Dec 209,4371,4251,5450
30 Sep 208,3611,1011,4140
30 Jun 207,5317491,3780
31 Mar 207,6577711,3760
31 Dec 197,7268351,4570
30 Sep 197,6397091,4020
30 Jun 197,5727071,4060
31 Mar 197,5387201,3870
31 Dec 187,5317331,3950
30 Sep 187,5578601,3780
30 Jun 187,5248081,3590
31 Mar 187,4697821,3720
31 Dec 177,4027691,4210
30 Sep 177,3986711,4130
30 Jun 177,4277011,4800
31 Mar 177,4697021,5580
31 Dec 167,2146421,3370
30 Sep 167,5036751,6240
30 Jun 167,4988251,6370
31 Mar 167,5177481,6370
31 Dec 157,4937061,6160
30 Sep 157,5277031,6540
30 Jun 157,5514911,6570
31 Mar 157,5285071,6510
31 Dec 147,4355491,6350
30 Sep 147,3085061,6380
30 Jun 147,1927801,6200
31 Mar 147,1057991,6200
31 Dec 137,1468111,6320

Kwaliteitswinsten: DGX heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (8.8%) DGX } zijn hoger dan vorig jaar (8.2%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van DGX is de afgelopen 5 jaar met 5.7% per jaar gedaald.

Versnelling van de groei: De winstgroei van DGX over het afgelopen jaar ( 10.4% ) overtreft het 5-jarig gemiddelde ( -5.7% per jaar).

Winst versus industrie: De winstgroei DGX over het afgelopen jaar ( 10.4% ) overtrof de Healthcare -sector 10.3%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 12.9% ) van DGX wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden